Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Parkinson's Disease

  Free Subscription


1 Ann Pharmacother
1 BMC Neurosci
1 Brain Res
3 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
7 Mov Disord
1 Neurobiol Dis
1 Neuropsychology
1 Neurosci Lett
1 Neuroscience
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Pharmacother

  1. KIM S, Cheon SM, Suh HS
    Association Between Drug Exposure and Occurrence of Parkinsonism in Korea: A Population-Based Case-Control Study.
    Ann Pharmacother. 2019 Jun 19:1060028019859543. doi: 10.1177/1060028019859543.
    PubMed     Text format     Abstract available

    BMC Neurosci

  2. YAN J, Yang Z, Zhao N, Li Z, et al
    Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
    BMC Neurosci. 2019;20:31.
    PubMed     Text format     Abstract available

    Brain Res

  3. LAI JH, Chen KY, Chung-Che Wu J, Olson L, et al
    Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
    Brain Res. 2019 Jun 18:146301. doi: 10.1016/j.brainres.2019.146301.
    PubMed     Text format     Abstract available

    J Neural Transm (Vienna)

  4. CSOTI I, Herbst H, Urban P, Woitalla D, et al
    Polypharmacy in Parkinson's disease: risks and benefits with little evidence.
    J Neural Transm (Vienna). 2019 Jun 20. pii: 10.1007/s00702-019-02026.
    PubMed     Text format     Abstract available

  5. STORCH A, Rosqvist K, Ebersbach G, Odin P, et al
    Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease.
    J Neural Transm (Vienna). 2019 Jun 19. pii: 10.1007/s00702-019-02033.
    PubMed     Text format     Abstract available

  6. RICHTER D, Bartig D, Jost W, Jorges C, et al
    Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.
    J Neural Transm (Vienna). 2019 Jun 20. pii: 10.1007/s00702-019-02034.
    PubMed     Text format     Abstract available

    J Neurol Neurosurg Psychiatry

  7. AVENALI M, Toffoli M, Mullin S, McNeil A, et al
    Evolution of prodromal parkinsonian features in a cohort of GBA mutation-positive individuals: a 6-year longitudinal study.
    J Neurol Neurosurg Psychiatry. 2019 Jun 20. pii: jnnp-2019-320394.
    PubMed     Text format     Abstract available

    Mov Disord

  8. RICCIARDI L, Sorbera C, Barbuto M, Morgante F, et al
    Sleep disturbances are mainly improved by deep brain stimulation of the subthalamic nucleus.
    Mov Disord. 2019;34:154-155.
    PubMed     Text format    

    Dopamine and eating behavior disorders in Parkinson's disease: A complex recipe.
    Mov Disord. 2019;34:767-768.
    PubMed     Text format    

  10. OBESO JA
    Editor's note: The origin of Parkinson's disease: The importance of environment and lifestyle.
    Mov Disord. 2019;34:799-800.
    PubMed     Text format    

  11. TEIVE HAG, Camargo CHF, Munhoz RP
    Reply to: Early distinction of Parkinson variant multiple system atrophy from Parkinson's disease.
    Mov Disord. 2019;34:929.
    PubMed     Text format    

  12. JABARKHEEL Z, Wagle Shukla A
    Essential requisites for rest tremor assessment in Parkinson's disease.
    Mov Disord. 2019;34:927-929.
    PubMed     Text format    

  13. MATARAZZO M, Arroyo-Gallego T, Montero P, Puertas-Martin V, et al
    Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer.
    Mov Disord. 2019 Jun 18. doi: 10.1002/mds.27772.
    PubMed     Text format     Abstract available

    Changing views of the pathophysiology of Parkinsonism.
    Mov Disord. 2019 Jun 19. doi: 10.1002/mds.27741.
    PubMed     Text format     Abstract available

    Neurobiol Dis

  15. MARIANI LL, Longueville S, Girault JA, Herve D, et al
    Differential enhancement of ERK, PKA and Ca(2+) signaling in direct and indirect striatal neurons of Parkinsonian mice.
    Neurobiol Dis. 2019 Jun 17:104506. doi: 10.1016/j.nbd.2019.104506.
    PubMed     Text format     Abstract available


  16. JONES JD, Burroughs M, Apodaca M, Bunch J, et al
    Greater intraindividual variability in neuropsychological performance predicts cognitive impairment in de novo Parkinson's disease.
    Neuropsychology. 2019 Jun 20. pii: 2019-33672-001. doi: 10.1037/neu0000577.
    PubMed     Text format     Abstract available

    Neurosci Lett

  17. BUARD I, Dewispelaere WD, Teale P, Rojas DC, et al
    Auditory Entrainment of Motor Responses in Older Adults with and without Parkinson's disease: an MEG study.
    Neurosci Lett. 2019 Jun 18:134331. doi: 10.1016/j.neulet.2019.134331.
    PubMed     Text format     Abstract available


  18. CHURCHILL MJ, Cantu MA, Kasanga EA, Moore C, et al
    Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson's disease.
    Neuroscience. 2019 Jun 17. pii: S0306-4522(19)30412.
    PubMed     Text format     Abstract available

    PLoS One

  19. NUNES A, Silva G, Duque C, Januario C, et al
    Retinal texture biomarkers may help to discriminate between Alzheimer's, Parkinson's, and healthy controls.
    PLoS One. 2019;14:e0218826.
    PubMed     Text format     Abstract available

  20. YANG YR, Cheng SJ, Lee YJ, Liu YC, et al
    Cognitive and motor dual task gait training exerted specific training effects on dual task gait performance in individuals with Parkinson's disease: A randomized controlled pilot study.
    PLoS One. 2019;14:e0218180.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.